Wealthedge Investment Advisors »

Acrivon Therapeutics shares owned by Wealthedge Investment Advisors

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Wealthedge Investment Advisors from 13F filings

Historical chart of Wealthedge Investment Advisors investment in Acrivon Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00165.358k65.3585k65.359k65.3595k65.36k10.856k10.8565k10.857k10.8575k10.858k
Value ($)Share countHistorical ACRV position of Wealthedge Investment Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Wealthedge Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $65k 11k 6.02

More positions owned by Wealthedge Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr Russell 3000 Etf (IWV)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)

View all positions for Wealthedge Investment Advisors

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Sands Capital Ventures
Citadel Advisors
BlackRock
Wellington Management Company
Vanguard Group
Marshall Wace
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Northern Trust
Charles Schwab Investment Management
DAFNA Capital Management
UBS O'Connor

View all funds holding Acrivon Therapeutics